Two Sigma Investments’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-53,950
| Closed | -$595K | – | 3409 |
|
|
2024
Q4 | $595K | Sell |
53,950
-62,728
| -54% | -$692K | ﹤0.01% | 2396 |
|
|
2024
Q3 | $1.43M | Buy |
116,678
+1,773
| +2% | +$21.8K | ﹤0.01% | 1832 |
|
|
2024
Q2 | $1.55M | Buy |
114,905
+99,405
| +641% | +$1.34M | ﹤0.01% | 1657 |
|
|
2024
Q1 | $209K | Buy |
15,500
+4,300
| +38% | +$58.1K | ﹤0.01% | 2624 |
|
|
2023
Q4 | $58.9K | Sell |
11,200
-17,100
| -60% | -$89.9K | ﹤0.01% | 2894 |
|
|
2023
Q3 | $112K | Buy |
28,300
+7,800
| +38% | +$30.7K | ﹤0.01% | 2653 |
|
|
2023
Q2 | $218K | Buy |
20,500
+3,500
| +21% | +$37.2K | ﹤0.01% | 2538 |
|
|
2023
Q1 | $142K | Sell |
17,000
-4,754
| -22% | -$39.6K | ﹤0.01% | 2547 |
|
|
2022
Q4 | $201K | Sell |
21,754
-15,990
| -42% | -$148K | ﹤0.01% | 2334 |
|
|
2022
Q3 | $485K | Buy |
37,744
+21,741
| +136% | +$279K | ﹤0.01% | 1747 |
|
|
2022
Q2 | $211K | Buy |
16,003
+4,761
| +42% | +$62.8K | ﹤0.01% | 2076 |
|
|
2022
Q1 | $237K | Sell |
11,242
-11,285
| -50% | -$238K | ﹤0.01% | 2255 |
|
|
2021
Q4 | $540K | Sell |
22,527
-58,022
| -72% | -$1.39M | ﹤0.01% | 1955 |
|
|
2021
Q3 | $2.05M | Sell |
80,549
-25,365
| -24% | -$645K | ﹤0.01% | 1353 |
|
|
2021
Q2 | $3.57M | Sell |
105,914
-21,452
| -17% | -$722K | 0.01% | 1067 |
|
|
2021
Q1 | $4.95M | Buy |
127,366
+102,426
| +411% | +$3.98M | 0.01% | 832 |
|
|
2020
Q4 | $1.55M | Buy |
+24,940
| New | +$1.55M | ﹤0.01% | 1180 |
|